
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    [{"authors":null,"categories":null,"content":"I am a Computational Biologist Post-doctoral Research Fellow with Dr. Felix Feng at the University of California, San Francisco (UCSF). My primary research location is the UCSF HDFC Cancer Center. Additionally, I hold the position of Adjunct Research Scientist at the Nepal Applied Mathematics \u0026amp; Informatics Institute (NAAMII), where I lead Computational Genomics Lab.\nMy main interest lies in understanding cancer progression and treatment resistance through the development and application of computational genomics approaches. [My Curriculum Vitae]\n","date":1686182400,"expirydate":-62135596800,"kind":"term","lang":"en","lastmod":1686182400,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"","publishdate":"0001-01-01T00:00:00Z","relpermalink":"","section":"authors","summary":"I am a Computational Biologist Post-doctoral Research Fellow with Dr. Felix Feng at the University of California, San Francisco (UCSF). My primary research location is the UCSF HDFC Cancer Center. Additionally, I hold the position of Adjunct Research Scientist at the Nepal Applied Mathematics \u0026 Informatics Institute (NAAMII), where I lead Computational Genomics Lab.","tags":null,"title":"Raunak Shrestha","type":"authors"},{"authors":[],"categories":null,"content":"","date":1698224400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1698224400,"objectID":"992004072a47ef8a7b14fec5ac99ebad","permalink":"/talk/30th-annual-pcf-scientific-retreat/","publishdate":"2023-07-28T00:00:00Z","relpermalink":"/talk/30th-annual-pcf-scientific-retreat/","section":"event","summary":"","tags":[],"title":"30th Annual PCF Scientific Retreat","type":"event"},{"authors":[],"categories":null,"content":"","date":1691226000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1691226000,"objectID":"b904091295cdaa83846bbfd086e50c94","permalink":"/talk/2023-gordon-research-conference-hormone-dependent-cancers/","publishdate":"2023-07-28T00:00:00Z","relpermalink":"/talk/2023-gordon-research-conference-hormone-dependent-cancers/","section":"event","summary":"","tags":[],"title":"2023 Gordon Research Conference - Hormone-Dependent Cancers","type":"event"},{"authors":["A Lundberg","M Zhang","R Aggarwal","H Li","L Zhang","A Foye","M Sjostrom","J Chou","K Chang","T Moreno-Rodriguez","Raunak Shrestha","A Baskin","X Zhu","AS Weinstein","N Younger","JJ Alumkal","TM Beer","KN Chi","CP Evans","M Gleave","PN Lara","RE Reiter","MB Rettig","ON Witte","AW Wyatt","FY Feng","EJ Small","DA Quigley"],"categories":null,"content":"","date":1686182400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1686182400,"objectID":"7251300d6738d2e73260026ac33b08c8","permalink":"/publication/2023_dnpc/","publishdate":"2023-06-08T00:00:00Z","relpermalink":"/publication/2023_dnpc/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"The genomic and epigenomic landscape of double-negative metastatic prostate cancer","type":"publication"},{"authors":["RK Shrestha","Raunak Shrestha","S Shneiderman","J Baniya"],"categories":null,"content":"","date":1679097600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1679097600,"objectID":"e998754d6e0d9e5dd320db969f46fb4e","permalink":"/publication/2023_happiness/","publishdate":"2023-03-18T00:00:00Z","relpermalink":"/publication/2023_happiness/","section":"publication","summary":"","tags":null,"title":"Beyond Reconstruction: What Leads to Satisfaction in Post-Disaster Recovery?","type":"publication"},{"authors":null,"categories":null,"content":"Systems Genomics Modelling of Drug Resistance in Mycobacterium tuberculosis Multi-drug resistance presents a growing challenge to global tuberculosis (TB) control efforts, with a particularly pressing concern in developing nations where robust disease surveillance and monitoring are lacking. Nepal is one of the countries with a high TB burden. TB is caused by an airborne bacterium, Mycobacterium tuberculosis (Mtb). Treatment for TB involves antibiotics, however, some Mtb becomes resistant to these drugs, forming drug-resistant TB, which is rapidly increasing and poses a major health threat. The emergence of drug resistance TB is linked to specific mutations in Mtb genome. However, the genetic foundations of drug resistance in TB are not fully understood. The existing catalog of well-characterized Mtb drug-resistant mutations falls short in elucidating numerous instances of drug-resistant TB. Identifying new drug-resistant TB mutations is challenging given the genetic diversity of TB and the complex mechanisms driving the drug resistance. To address these challenges, here, we aim to develop a machine learning method to predict drug-resistant TB leveraging a large pool of TB genomic data. Additionally, we will explore the underlying metabolic adaptation in drug-resistant TB using genome-scale metabolic modeling.\nResearch Funded by ","date":1672704000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1672704000,"objectID":"818ac328f5717af26998e2adb567d76d","permalink":"/research_naamii/tb_drug_resistance/","publishdate":"2023-01-03T00:00:00Z","relpermalink":"/research_naamii/tb_drug_resistance/","section":"research_naamii","summary":"Using genome informatics to understand and better coltrol TB multi-drug resistance","tags":["TB","Tuberculosis","Infectious Disease"],"title":"Tuberculosis multi-drug resistance","type":"research_naamii"},{"authors":null,"categories":null,"content":"Mining Dengue virus immunopeptidome for next-generation dengue vaccine Dengue is a viral infection caused by the Dengue virus (DENV), transmitted to humans through the bite of infected mosquitoes, particularly female Aedes aegypti and A. albopictus. Dengue presents an escalating global public health crisis, endangering nearly half of the world’s population at a significantly high level of risk. Preventing severe dengue cases by vaccination is crucial for reducing the overall disease burden, minimizing hospitalizations, and saving lives. Currently, available dengue vaccines are ineffective in providing complete immunity against all serotypes of the virus, and their efficacy varies widely across different age groups and prior dengue exposure statuses. Thus, there is an urgent need for a balanced dengue vaccine effective against all DENV serotypes. For this, we aim to discover new molecular targets essential for the development of a more effective next-generation dengue vaccine.\n","date":1672617600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1672617600,"objectID":"c43a68368aeac6e0c61b2e890a8b0870","permalink":"/research_naamii/dengue_vaccine/","publishdate":"2023-01-02T00:00:00Z","relpermalink":"/research_naamii/dengue_vaccine/","section":"research_naamii","summary":"Mining Dengue virus immunopeptidome for next-generation dengue vaccine","tags":["Dengue","Immune","Infectious Disease"],"title":"Developing efficient dengue vaccine","type":"research_naamii"},{"authors":null,"categories":null,"content":"The coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) rapidly escalated into a global pandemic. Nepal detected its first case in January 2020, and since then, the country has grappled with over a million infections and a significant loss of life. Throughout the pandemic, scientists have diligently studied the virus’s genetic composition and its evolving transmission patterns. Various geographic regions have experienced multiple waves of infection, each dominated by a novel virus variant. Notably, some of these emerging strains pose challenges to the effectiveness of existing vaccines. Understanding these variants, their origins, and their spread within communities is crucial for future pandemic preparedness. In Nepal, researchers have made significant progress by sharing thousands of SARS-CoV-2 genome sequences publicly. However, comprehensive investigation on these cases has not been conducted till date. This study aims to conduct a comprehensive genomic analysis of SARS-CoV-2 transmission in Nepal. We will investigate virus’s genetic diversity, evolutionary trajectory, and epidemiological patterns. Our long-term vision is to create bioinformatics pipelines and platforms which could be readily deployed in case of any future epidemics or pandemics which will help us understand the transmission of the infectious disease and enable rapid intervention of the disease. Toward this goal, we have created the “Nepal SARS-CoV-2 Genome Database”, a comprehensive phylogenetic clustering of SARS-CoV-2 genomes from Nepal using Nextstrain, a powerful open-source tool for the real-time interactive visualization of genome sequencing data.\n","date":1672531200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1672531200,"objectID":"bc2d26f94c429f47d08c651507dd53da","permalink":"/research_naamii/covid19_genomics/","publishdate":"2023-01-01T00:00:00Z","relpermalink":"/research_naamii/covid19_genomics/","section":"research_naamii","summary":"Understaning transmission patterns of COVID-19","tags":["COVID19","SARS","Infectious Disease"],"title":"Genomic epidemiology of SARS-CoV-2","type":"research_naamii"},{"authors":["M Sjostrom","SG Zhao","S Levy","M Zhang","Y Ning","Raunak Shrestha","A Lundberg","C Herberts","A Foye","R Aggarwal","JT Hua","H Li","A Bergamaschi","C Maurice-Dror","A Maheshwari","S Chen","SWS Ng","W Ye","J Petricca","M Fraser","L Chesner","MD Perry","T Moreno-Rodriguez","WS Chen","JJ Alumkal","J Chou","AK Morgans","TM Beer","GV Thomas","M Gleave","P Lloyd","T Phillips","E McCarthy","MC Haffner","A Zoubeidi","M Annala","RE Reiter","MB Rettig","ON Witte","L Fong","R Bose","FW Huang","J Luo","A Bjartell","JM Lang","NP Mahajan","PN Lara","CP Evans","PT Tran","EM Posadas","C He","X Cui","J Huang","W Zwart","LA Gilbert","CA Maher","PC Boutros","KN Chi","A Ashworth","EJ Small","HH He","AW Wyatt","DA Quigley","FY Feng"],"categories":null,"content":"","date":1667347200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1667347200,"objectID":"2d1f6e98020191c44f03a973ea3df888","permalink":"/publication/2022_prostate5hmc/","publishdate":"2022-11-02T00:00:00Z","relpermalink":"/publication/2022_prostate5hmc/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"The 5-Hydroxymethylcytosine Landscape of Prostate Cancer","type":"publication"},{"authors":["Raunak Shrestha"],"categories":["grant"],"content":"The Prostate Cancer Foundation (PCF) today announced the Class of 2022 Young Investigator Award recipients totaling $7.2 million in funding for innovative prostate cancer research.\nPCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the field of prostate cancer research vibrant with new ideas and offer career and project support for early career physicians and scientists who are committed to advancing the prostate cancer field. Thirty-four PCF Young Investigator Awards totaling $7.2 million were granted to the promising next generation of cancer researchers.\nRaunak Shrestha, PhD was one of the PCF-Young Investigator awardee. His research award was generously sponsored by Mr. Todd Boehly\nPCF-Young Investigator Class of 2022\n","date":1666828800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1666828800,"objectID":"8436688584a199095656bb8a4f53ce75","permalink":"/post/pcfyi_2022/","publishdate":"2022-10-27T00:00:00Z","relpermalink":"/post/pcfyi_2022/","section":"post","summary":"PCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the field of prostate cancer research vibrant with new ideas and offer career and project support for early career physicians and scientists who are committed to advancing the prostate cancer field.","tags":["pcf"],"title":"Raunak Shrestha receives Todd Boehly - Prostate Cancer Foundation Young Investigator Award - 2022","type":"post"},{"authors":[],"categories":null,"content":"","date":1666688400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1666688400,"objectID":"9869be90cd1d373afe7c330b1bd8ded7","permalink":"/talk/29th-annual-pcf-scientific-retreat/","publishdate":"2022-07-28T00:00:00Z","relpermalink":"/talk/29th-annual-pcf-scientific-retreat/","section":"event","summary":"","tags":[],"title":"29th Annual PCF Scientific Retreat","type":"event"},{"authors":[],"categories":null,"content":"","date":1639958400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1639958400,"objectID":"7c10bd6568c6df37035320157253f373","permalink":"/talk/third-nepal-winter-school-in-ai/","publishdate":"2021-12-18T00:00:00Z","relpermalink":"/talk/third-nepal-winter-school-in-ai/","section":"event","summary":"","tags":[],"title":"Third Nepal Winter-School in AI","type":"event"},{"authors":["N Rydzewski","JM Lang","M Yu","M Sjostrom","SL Chang","W Chen","Raunak Shrestha","M Zhang","DA Quigley","R Aggarwal","E Small","DR Wahl","FY Feng","SG Zhao"],"categories":null,"content":"","date":1632182400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1632182400,"objectID":"b3cf9ef370d777d1a1817d5e752a6cf7","permalink":"/publication/2021_target/","publishdate":"2021-09-21T00:00:00Z","relpermalink":"/publication/2021_target/","section":"publication","summary":"","tags":null,"title":"Predicting Cancer Drug TARGETS - TreAtment Response GlmnET Signatures","type":"publication"},{"authors":["R Das","M Sjostrom","Raunak Shrestha","C Yogodzinski","EA Egusa","L Chesner","WS Chen","J Chou","DK Dang","JT Swinderman","A Ge","JT Hua","S Kabir","DA Quigley","EJ Small","A Ashworth","FY Feng","LA Gilbert"],"categories":null,"content":"","date":1627603200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1627603200,"objectID":"52698ddbf44a3cd81976fbcaa6b4bd7f","permalink":"/publication/2021_prostatecrispr/","publishdate":"2021-07-30T00:00:00Z","relpermalink":"/publication/2021_prostatecrispr/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer","type":"publication"},{"authors":["Raunak Shrestha","M Llaurado Fernandez","A Dawson","J Hoenisch","S Volik","Y Lin","S Anderson","H Kim","A Haegert","S Colborne","N Wong","B McConeghy","RH Bell","S Brahmbhatt","C Lee","GE DiMattia","S Le Bihan","GB Morin","CC Collins","MS Carey"],"categories":null,"content":"","date":1610582400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1610582400,"objectID":"546e5c158fc8730a6bc998b0f0e096e6","permalink":"/publication/2021_lgsoc/","publishdate":"2021-01-13T00:00:00Z","relpermalink":"/publication/2021_lgsoc/","section":"publication","summary":"LGSOC is a rare tumor subtype with high case fatality rates in patients with metastatic disease. Here, we use multiomics integration of whole-exome sequencing, RNA sequencing, and mass spectrometry–based proteomics on LGSOC cell lines to elucidate novel biomarkers and therapeutic vulnerabilities.","tags":["Cancer"],"title":"Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability","type":"publication"},{"authors":["WS Chen","WA Haynes","R Waitz","K Kamath","A Vega-Crespo","Raunak Shrestha","M Zhang","A Foye","IB Carretero","IG Perez","M Zhang","SG Zhao","M Sjostrom","DA Quigley","J Chou","TM Beer","M Rettig","M Gleave","CP Evans","P Lara","KN Chi","RE Reiter","JJ Alumkal","R Aggarwal","EJ Small","PS Daugherty","A Ribas","DY Oh","JC Shon","FY Feng"],"categories":null,"content":"","date":1600819200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1600819200,"objectID":"efb6e435fbdd5fb2083e2d97e2e711b0","permalink":"/publication/2020_prostateab/","publishdate":"2020-09-23T00:00:00Z","relpermalink":"/publication/2020_prostateab/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"Autoantibody landscape in patients with advanced prostate cancer","type":"publication"},{"authors":["E Hodzic","Raunak Shrestha","S Malikic","CC Collins","K Litchfield","S Turajlic","SC Sahinalp"],"categories":null,"content":"Delighted to share our paper describing an algorithm CONETT to identify Conserved Evolutionary Trajectory Tree from multiple tumors. This paper will be presented at the #ISMB2020 conference next week. @cenksahinalp https://t.co/9uMAoaPDoQ pic.twitter.com/uV1NO23tDe\n— Raunak Shrestha (@raunakms) July 15, 2020 ","date":1594598400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1594598400,"objectID":"adcfe9b05a4be4dd0e3c5b4a40e0fcc7","permalink":"/publication/2020_conett/","publishdate":"2020-07-13T00:00:00Z","relpermalink":"/publication/2020_conett/","section":"publication","summary":"Delighted to share our paper describing an algorithm CONETT to identify Conserved Evolutionary Trajectory Tree from multiple tumors. This paper will be presented at the #ISMB2020 conference next week. @cenksahinalp https://t.","tags":["Cancer","Algorithms","Networks"],"title":"Identification of Conserved Evolutionary Trajectories in Tumors","type":"publication"},{"authors":[],"categories":null,"content":" ","date":1592733600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1592733600,"objectID":"22e775edc707310f286663de98383ee9","permalink":"/talk/cancer-genomics-and-precision-oncology/","publishdate":"2020-06-21T18:00:00Z","relpermalink":"/talk/cancer-genomics-and-precision-oncology/","section":"event","summary":" ","tags":[],"title":"Cancer Genomics and Precision Oncology","type":"event"},{"authors":["Raunak Shrestha","N Nabavi","S Volik","S Anderson","A Haegert","B McConeghy","F Sar","S Brahmbhatt","RH Bell","S Le Bihan","Y Wang","CC Collins","A Churg"],"categories":null,"content":"Happy to share our paper published today on genomic characterization of a rare form of a very rare cancer, Well-Differentiated Papillary Mesothelioma (WDPM) of the Peritoneum https://t.co/khLK683Y4P #mesothelioma #PeritonealMesothelioma #WDPM @Cancers_MDPI pic.twitter.com/7pvE42nLTo\n— Raunak Shrestha (@raunakms) June 13, 2020 ","date":1592006400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1592006400,"objectID":"20d79ea663dd4d9417c5933c48574b94","permalink":"/publication/2020_wdpm/","publishdate":"2020-06-13T00:00:00Z","relpermalink":"/publication/2020_wdpm/","section":"publication","summary":"WDPM is an uncommon mesothelial proliferation that is most commonly encountered as an incidental finding in the peritoneal cavity. Here we show that WDPMs are neoplasms that are genetically distinct from malignant mesotheliomas.","tags":["Mesothelioma"],"title":"Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma","type":"publication"},{"authors":["RK Shrestha","Raunak Shrestha"],"categories":null,"content":"","date":1589587200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1589587200,"objectID":"0c345eb5147992ad471464971041378e","permalink":"/publication/2020_cookingfuel/","publishdate":"2020-05-16T00:00:00Z","relpermalink":"/publication/2020_cookingfuel/","section":"publication","summary":"","tags":null,"title":"Group segmentation and heterogeneity in the choice of cooking fuels in post-earthquake Nepal","type":"publication"},{"authors":["Raunak Shrestha"],"categories":["Nepal","Infectious Disease"],"content":"Article Published in NepalKhabar April 16, 2020. बैशाख ४, २०७७\nकोरोना भाइरस पहिचानका लागि नेपालमा नमुना संकलनको क्रम बढाउँदै लगिए पनि त्यस अनुपातमा परीक्षण बढाउन सकिएको छैन। यसकाे मुख्य कारण हाे- नेपालमै भएका प्रयोगशाला, उपकरण र दक्ष प्राविधिज्ञको पूर्ण सदुपयोग गर्न नसक्नु।\nअहिले नेपालसहित विश्वका २ सयभन्दा बढी मुलुकमा कोरोना भाइरस (कोभिड-१९) को संक्रमण फैलिएको छ। चीनबाट सुरु भएको यो महामारीको केन्द्र पछिल्लो समय युरोप र अमेरिका बनेका छन्। नेपालमा पनि स्थानीय स्तरमा एक महिला संक्रमित भएसँगै यो महामारी दोस्रो चरणमा प्रवेश गरेको छ।\nकेही दिनयता निरन्तर संक्रमित भेटिन थालेका छन्। यसर्थ कोरोनाविरुद्ध थप सतर्कता अपनाउन र परीक्षण तीव्र पार्न आवश्यक छ। नेपाल सरकारले कोभिड-१९ को संक्रमण पत्ता लगाउन र्‍यापिड डायग्नस्टिक टेस्ट (आरडीटी) र पीसीआर दुवै विधि अपनाएको छ।\nवैज्ञानिक नाम सार्स-कोभ-२ भाइरसको संक्रमण जाँच्ने दुई तरिका छन्: र्‍यापिड डायग्नस्टिक टेस्ट (आरडीटी) र पोलिमरेज चेन रियाक्सन (पीसीआर) टेस्ट। आरडीटी- व्यक्ति वा समुदायमा भाइरस संक्रमण छ कि छैन भनेर गरिने परीक्षण हो। कसैमा भाइरस संक्रमण भएमा उसको शरीरभित्र भाइरससँग लड्न रोग-प्रतिरोधात्मक एन्टिबडी प्रोटिन (आईजीएम र आईजीजी) उत्पादन हुन्छन्। यही एन्टिबडी प्रोटिनको मद्दतले ऊ आफैँ ठीक पनि हुन सक्छ। भविष्यमा पनि यही एन्टिबडी प्रोटिनले कोरोना भाइरस संक्रमणको जोखिम कम गर्छ।\nतर आरडीटी परीक्षणले आजका दिनमा भाइरस संक्रमण छ वा छैन भन्ने सूचना दिन सक्दैन। पीसीआर विधिले भने कोरोना भाइरस छ वा छैन भन्ने जानकारी दिन सक्छ। नयाँ संक्रमण पहिचान गर्न सक्छ। यसका लागि मानिसको नाक वा घाँटी भित्रबाट नमुना (तरल पदार्थ) लिइन्छ।\nनेपालमा प्रयोग भइरहेको आरडीटी विधिले मानिसको रगतमा एन्टिबडी प्रोटिन छ वा छैन भनी परीक्षण गर्छ। कसैमा भाइरस संक्रमण भएमा यो एन्डिबडी प्रोटिन बन्न केही दिन लाग्छ। भाइरस संक्रमण भएको ७ दिनदेखि ६ महिनासम्म (वा योभन्दा पनि बढी) यो एन्डिबडी प्रोटिन मानिसको रगतमा रहिरन्छ। रगतमा यो एन्डिबडी प्रोटिन देखिए, आरडीटी परीक्षणको नतिजा पोजिटिभ आउँछ।\nतर भाइरस संक्रमण भएको १ देखि ७ दिनसम्म आरडीटी परीक्षण गर्दा नतिजा नेगेटिभ आउँछ। किनभने यो भाइरस संक्रमणको प्रारम्भिक चरणमा शरीरभित्र भाइरस भए पनि रगतमा एन्डिबडी प्रोटिन बनिसकेको हुँदैन। त्यसैले आरडीटीमा नेगेटिभ देखिएका हरेक मानिसमा पीसीआर परीक्षण गर्न जरुरी हुन्छ। तर नेपालमा आरडीटीमा नेगेटिभ देखिएका मानिसमा कोभिड-१९ का लक्षण देखिए मात्र फेरि पीसीआर परीक्षण गर्ने गरिएको छ। यसले गर्दा धेरै जना संक्रमित पहिचान गर्नबाट छुटेका हुन सक्छन्।\nहालै वीरगन्जको क्वारेन्टिनमा रहेकी एक महिलालाई आरडीटी परीक्षण गर्दा नतिजा नेगेटिभ आएपछि आफ्नो घर कैलाली पठाइयो, तर फेरि पीसीआर परीक्षण गर्दा नतिजा पोजिटिभ आयो। यसको मतलब ती महिलामा भाइरस संक्रमणको प्रारम्भिक चरणमा थियो, जुन आरडीटीले पहिचान गर्न सकेन। पीसीआरले गर्‍याे।\nभाइरस संक्रमण भएको ७–२१ दिनभित्र आरडीटी परीक्षण गरियो भने नतिजा पोजिटिभ आउँछ। पीसीआर परीक्षण गर्दा पनि पोजिटिभै आउँछ। यसको अर्थ उसमा भाइरस भएको, संक्रमण मध्यम चरणमा रहेको र एन्डिबडी प्रोटिन पनि बनेको प्रमाणित हुन्छ। भाइरस संक्रमण भएको १४–२१ दिन बितिसकेको अवस्थामा आरडीटी परीक्षण गर्दा नतिजा पोजिटिभ आउँछ। तर पीसीआर परीक्षण गर्दा रिपोर्ट नेगेटिभ आउन सक्छ।\nयसको अर्थ उसमा हाल संक्रमण नरहेको वा निको हुने चरणमा रहेको भनी बुझ्न सकिन्छ। अहिले नेपालमा कतिपय स्थानमा भइरहेको पनि यही हो। आरडीटी गर्दा पोजिटिभ देखिन्छ भने पीसीआर गर्दा नेगेटिभ।\nहालै काठमाडौं पेप्सिकोलास्थित सनसिटी अपार्टमेन्टमा एकै परिवारका तीन जना (आमा, छोरा र बुहारी) बेलायतबाट कतार हुँदै काठमाडौं आएको करिब तीन साता बितिसकेको थियो। तीनै जनाको पहिले आरडीटीबाट परीक्षण गर्दा नतिजा पोजिटिभ देखियो, तर पुनः पीसीआर परीक्षण गर्दा आमा र छोरामा कोरोना देखियो भने बुहारीमा देखिएन। यसमा कुनै शंका नरहोस्, तीनै जना संक्रमित हुन्।\nआमा र छोराको शरीरभित्र अहिलेसम्म भाइरस छ, तर बुहारीको शरीरबाट हटिसकेको छ। बुहारीलाई विदेशमै भाइरस संक्रमण भएको र पछि उनीबाट आमा र छोरालाई सरेको (स्थानीय संक्रमण) हुन सक्छ। संक्रमित परिवारका सम्पर्कमा आएका मानिसको आरडीटीबाट परीक्षण गर्दा नतिजा नेगेटिभ आए पनि पुनः पीसीआर परीक्षण गर्न जरुरी छ।\nआरडीटी र पीसीआर दुवै परीक्षणमा नतिजा नेगेटिभ आए मात्र भाइरस संक्रमण नभएको पुष्टि हुन्छ।\nआरडिटी परिक्षण पिसिआर परिक्षण नतिजाको अर्थ नेगेटिभ पोजेटिभ भाइरस संक्रमण भएको १-७ दिन भित्र (प्रारम्भिक चरण) अवस्था, शरिरभित्र आजको दिनमा भाइरस रहेको अवस्था पोजेटिभ पोजेटिभ भाइरस संक्रमण भएको ७-२१ दिन (मध्यम चरण) अवस्था, शरिरभित्र आजको दिनमा भाइरस रहेको अवस्था पोजेटिभ नेगेटिभ भाइरस संक्रमण भएको १४-२१ दिन बितिसकिको अवस्था, शरिरबाट भाइरस हतिसकेको वा बिरामी निकोहुने चरणमा रहेको अवस्था नेगेटिभ नेगेटिभ भाइरस संक्रमण नभएको अवस्था पीसीआरभन्दा आरडीटी परीक्षणको मूल्य धेरै सस्तो पर्छ। आरडीटी परीक्षणको नतिजा २०–२५ मिनेटभित्र निकाल्न सकिन्छ भने पीसीआर परीक्षणको नतिजा १–४ घण्टा लाग्छ। आरडीटी परीक्षण गर्न कुनै बिजुली वा महँगो उपकरण चाहिँदैन र साधारण तालिमप्राप्त ल्याब असिस्टेन्टले यो टेस्ट गर्न सक्छन्। त्यसैले आरडीटी परीक्षण गाउँगाउँमा ठूलो समुदायमा गर्न सकिन्छ। पीसीआर एउटा जटिल प्रविधि हो र यसका लागि सुविधाजनक प्रयोगशाला र विशिष्ट तालिमप्राप्त प्राविधिकको आवश्यकता पर्छ। त्यसैले पीसीआर परीक्षण सुगम क्षेत्रमा मात्र सम्भव छ।\nविज्ञान-प्रविधिमा लगानी गर्ने अवसर नेपाल कोरोना भाइरस महामारीको दोस्रो चरणमा प्रवेश गरेको छ। यतिबेला नेपाल सरकारको पहिलो प्राथमिकता कोरोना भाइरस परीक्षण गरी संक्रमित पहिचान गर्नु हो। प्रारम्भिक दिनमा राष्ट्रिय जनस्वास्थ्य प्रयोगशाला (टेकु) मा मात्र पीसीआर परीक्षण हुन्थ्यो भने अहिले यो सेवा नेपालका …","date":1586995200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1586995200,"objectID":"8394d2d74a6892f27fe054e4e5f62d81","permalink":"/post/covid19_rdt_pcr_tests/","publishdate":"2020-04-16T00:00:00Z","relpermalink":"/post/covid19_rdt_pcr_tests/","section":"post","summary":"कोरोना भाइरस पहिचानका लागि नेपालमा नमुना संकलनको क्रम बढाउँदै लगिए पनि त्यस अनुपातमा परीक्षण बढाउन सकिएको छैन। यसकाे मुख्य कारण हाे- नेपालमै भएका प्रयोगशाला, उपकरण र दक्ष प्राविधिज्ञको पूर्ण सदुपयोग गर्न नसक्नु।","tags":["covid19","Nepal"],"title":"यस्तो अवस्थामा आउँछ आरडीटी नेगेटिभ, पीसीआर पोजिटिभ","type":"post"},{"authors":["NM D’Costa","MR Lowerison","PA Raven","Z Tan","ME Roberts","Raunak Shrestha","MW Urban","CU Monjaras-Avila","HZ Oo","A Hurtado-Coll","C Chavez-Munoz","AI So"],"categories":null,"content":"","date":1581292800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1581292800,"objectID":"e300d089f75b16dc3902d2542549d00d","permalink":"/publication/2020_ybox/","publishdate":"2020-02-10T00:00:00Z","relpermalink":"/publication/2020_ybox/","section":"publication","summary":"","tags":["Cancer"],"title":"Y-box Binding Protein-1 is Crucial in Acquired Drug Resistance Development in Metastatic Clear-Cell Renal Cell Carcinoma","type":"publication"},{"authors":["NM D'Costa","D Cina","Raunak Shrestha","RH Bell","YLin","H Asghari","CU Monjaras-Avila","C Kollmannsberger","F Hach","CI Chavez-Munoz","AI So"],"categories":null,"content":"","date":1580947200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1580947200,"objectID":"242f3cdc8e4fdef8bb5918039b486a0b","permalink":"/publication/2020_rcc/","publishdate":"2020-02-06T00:00:00Z","relpermalink":"/publication/2020_rcc/","section":"publication","summary":"","tags":["Cancer"],"title":"Identification of Predictive Gene Signature to Guide Precision Oncology of Clear-Cell Renal Cell Carcinoma","type":"publication"},{"authors":["PCAWG Consortium"],"categories":null,"content":"Great to co-author this landmark paper from the Pan-Cancer Analysis of Whole Genomes #PCWAG consortium published today in Nature https://t.co/pn5gwNYwHo https://t.co/ea39L5OiHu\n— Raunak Shrestha (@raunakms) February 5, 2020 ","date":1580860800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1580860800,"objectID":"1e51964deb9a398660bd555f49b315bf","permalink":"/publication/2020_pcawg_nature/","publishdate":"2020-02-05T00:00:00Z","relpermalink":"/publication/2020_pcawg_nature/","section":"publication","summary":"The PCAWG Project, conducted by the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes, employed comprehensive whole genome sequencing and integrated analysis techniques on more than 2,600 primary cancers and their corresponding normal tissues from 38 different tumor types.","tags":["Cancer"],"title":"Pan-cancer Analysis of Whole Genomes","type":"publication"},{"authors":["MA Reyna","D Haan","M Paczkowska","LPC Verbeke","M Vazquez","A Kahraman","S Pulido-Tamayo","J Barenboim","L Wadi","P Dhingra","Raunak Shrestha","G Getz","MS Lawrence","JS Pedersen","MA Rubin","DA Wheeler","S Brunak","JMG Izarzugaza","E Khurana","K Marchal","C von Mering","SC Sahinalp","A Valencia","J Reimand","JM Stuart","BJ Raphael","PCAWG Consortium"],"categories":null,"content":"","date":1580860800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1580860800,"objectID":"076ebb9228899ba58d59d6abe0a31d2e","permalink":"/publication/2020_pcawg_network/","publishdate":"2020-02-05T00:00:00Z","relpermalink":"/publication/2020_pcawg_network/","section":"publication","summary":"","tags":["Algorithms","Networks","Cancer"],"title":"Pathway and network analysis of more than 2,500 whole cancer genomes","type":"publication"},{"authors":["Raunak Shrestha","N Nabavi","Y Lin","F Mo","S Anderson","S Volik","H H Adomat","D Lin","H Xue","X Dong","R Shukin","RH Bell","B McConeghy","A Haegert","S Brahmbhatt","E Li","HZ Oo","A Hurtado-Coll","L Fazli","J Zhou","Y McConnell","A McCart","A Lowy","GB Morin","T Chen","M Daugaard","SC Sahinalp","F Hach","S Le Bihan","ME Gleave","Y Wang","A Churg","CC Collins"],"categories":null,"content":"Our paper describing a potentially new treatment for Peritoneal #Mesothelioma published today in @GenomeMedicine https://t.co/admejVvX5K @VanProstateCtr #PrecisionOncology #Immunotherapy #Cancer #Genomics (1/n) pic.twitter.com/mWrsjpTsr1\n— Raunak Shrestha (@raunakms) February 18, 2019 Great to see our work ( https://t.co/admejVvX5K ) making a mark in the field. Thanks @MLadanyi @fsanchezvega @MGZauderer for highlighting our work. https://t.co/s1cTVs2TgD #Mesothelioma #PeritonealMesothelioma #Immunotherapy\n— Raunak Shrestha (@raunakms) March 27, 2019 ","date":1549497600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549497600,"objectID":"fa25a8229c18d0f5baad9878123f702f","permalink":"/publication/2019_mesothelioma/","publishdate":"2019-02-07T00:00:00Z","relpermalink":"/publication/2019_mesothelioma/","section":"publication","summary":"Malignant peritoneal mesothelioma (PeM) is a rare and fatal cancer originating from the abdominal lining. Our study revealed that BAP1 could serve as a prognostic and predictive biomarker for immunotherapy in PeM.","tags":["Cancer","Mesothelioma","Precision Oncology"],"title":"BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma","type":"publication"},{"authors":["E Hodzic","Raunak Shrestha","K Zhu","K Cheng","CC Collins","SC Sahinalp"],"categories":null,"content":"Our latest publication in @GigaScience on an algorithm to identify patterns of similarity of molecular alterations between cancer patients. “Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks” #Bioinformatics https://t.co/V1MgtqOLkL pic.twitter.com/IRcUVtbnIG\n— Raunak Shrestha (@raunakms) April 11, 2019 ","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"58e1aebd2fc7ef2688b6bb866476a07e","permalink":"/publication/2019_cdcap/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/publication/2019_cdcap/","section":"publication","summary":"We introduce a novel combinatorial method, cd-CAP, for simultaneous detection of connected subnetworks of an interaction network where genes exhibit conserved alteration patterns across tumor samples.","tags":["Algorithms","Cancer","Networks"],"title":"Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks","type":"publication"},{"authors":[],"categories":[],"content":"Create slides in Markdown with Wowchemy Wowchemy | Documentation\nFeatures Efficiently write slides in Markdown 3-in-1: Create, Present, and Publish your slides Supports speaker notes Mobile friendly slides Controls Next: Right Arrow or Space Previous: Left Arrow Start: Home Finish: End Overview: Esc Speaker notes: S Fullscreen: F Zoom: Alt + Click PDF Export Code Highlighting Inline code: variable\nCode block:\nporridge = \u0026#34;blueberry\u0026#34; if porridge == \u0026#34;blueberry\u0026#34;: print(\u0026#34;Eating...\u0026#34;) Math In-line math: $x + y = z$\nBlock math:\n$$ f\\left( x \\right) = ;\\frac{{2\\left( {x + 4} \\right)\\left( {x - 4} \\right)}}{{\\left( {x + 4} \\right)\\left( {x + 1} \\right)}} $$\nFragments Make content appear incrementally\n{{% fragment %}} One {{% /fragment %}} {{% fragment %}} **Two** {{% /fragment %}} {{% fragment %}} Three {{% /fragment %}} Press Space to play!\nOne Two Three A fragment can accept two optional parameters:\nclass: use a custom style (requires definition in custom CSS) weight: sets the order in which a fragment appears Speaker Notes Add speaker notes to your presentation\n{{% speaker_note %}} - Only the speaker can read these notes - Press `S` key to view {{% /speaker_note %}} Press the S key to view the speaker notes!\nOnly the speaker can read these notes Press S key to view Themes black: Black background, white text, blue links (default) white: White background, black text, blue links league: Gray background, white text, blue links beige: Beige background, dark text, brown links sky: Blue background, thin dark text, blue links night: Black background, thick white text, orange links serif: Cappuccino background, gray text, brown links simple: White background, black text, blue links solarized: Cream-colored background, dark green text, blue links Custom Slide Customize the slide style and background\n{{\u0026lt; slide background-image=\u0026#34;/media/boards.jpg\u0026#34; \u0026gt;}} {{\u0026lt; slide background-color=\u0026#34;#0000FF\u0026#34; \u0026gt;}} {{\u0026lt; slide class=\u0026#34;my-style\u0026#34; \u0026gt;}} Custom CSS Example Let’s make headers navy colored.\nCreate assets/css/reveal_custom.css with:\n.reveal section h1, .reveal section h2, .reveal section h3 { color: navy; } Questions? Ask\nDocumentation\n","date":1549324800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1549324800,"objectID":"0e6de1a61aa83269ff13324f3167c1a9","permalink":"/slides/example/","publishdate":"2019-02-05T00:00:00Z","relpermalink":"/slides/example/","section":"slides","summary":"An introduction to using Wowchemy's Slides feature.","tags":[],"title":"Slides","type":"slides"},{"authors":null,"categories":null,"content":" ","date":1540976400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1540976400,"objectID":"9e4ecad12e3fd58b5b9a45201703f08a","permalink":"/talk/first-nepal-winter-school-in-ai/","publishdate":"2018-10-31T09:00:00Z","relpermalink":"/talk/first-nepal-winter-school-in-ai/","section":"event","summary":" ","tags":[],"title":"First Nepal Winter-School in AI","type":"event"},{"authors":null,"categories":null,"content":"","date":1537866000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1537866000,"objectID":"113f9b1baf45fa305dd65ee237709735","permalink":"/talk/inactivation-of-bap1-predicts-a-distinct-immunogenic-class-of-malignant-peritoneal-mesothelioma/","publishdate":"2018-09-25T09:00:00Z","relpermalink":"/talk/inactivation-of-bap1-predicts-a-distinct-immunogenic-class-of-malignant-peritoneal-mesothelioma/","section":"event","summary":"","tags":[],"title":"Inactivation of BAP1 Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma","type":"event"},{"authors":["Raunak Shrestha"],"categories":["data viz"],"content":"I defended my PhD in Bioinformatics from the University of British Columbia (UBC) on August 2018. My PhD thesis can be accessed from the UBC Library Collections. Here, I attempted to visualize bibliography in my PhD thesis. Hope you will find this interesting and useful.\nDownload the bibliography (.bib) file\nDefine Libraries library(\u0026#34;RefManageR\u0026#34;) library(\u0026#34;dplyr\u0026#34;) Read .bib file file.bib \u0026lt;- file.path(\u0026#34;raunak_shrestha_ubc_phd_thesis_bibliography_2018.bib\u0026#34;) bib \u0026lt;- suppressMessages(RefManageR::ReadBib(file.bib)) Convert bib object to dataframe dat \u0026lt;- as.data.frame(bib, row.names=NULL, optional=FALSE) val.year \u0026lt;- as.numeric(dat$year) Generate histogram of citations by year of publication h \u0026lt;- hist(val.year, breaks=30, plot=FALSE) xfit \u0026lt;- seq(min(val.year), max(val.year), length=30) yfit \u0026lt;- dnorm(xfit, mean=mean(val.year), sd=sd(val.year)) yfit \u0026lt;- yfit*diff(h$mids[1:2])*length(val.year) plot(h, col=c(\u0026#34;#fdbf6f\u0026#34;), main=\u0026#34;\u0026#34;, xlab=\u0026#34;Year of Publication\u0026#34;, ylab=\u0026#34;No. of Citations\u0026#34;, axes=FALSE, cex.main=1, cex.lab=1, cex.axis=1, las=1, tck=-0.03) lines(xfit, yfit, col=\u0026#34;#000000\u0026#34;, lwd=3) axis(side=1, at=seq(1985,2020,3), labels=TRUE, tick=TRUE, cex.axis=1, las=2, lwd=1, tck=-0.03) axis(side=2, at=seq(0,25,5), labels=TRUE, tick=TRUE, cex.axis=1, las=1, lwd=1, tck=-0.03) Distribution of citations by the journal of publication For the sake of visualization, we will restrict to top-20 journals dat1 \u0026lt;- dat[-which(is.na(dat$journal)),] df \u0026lt;- dat1 %\u0026gt;% dplyr::count(journal, sort=TRUE) df20 \u0026lt;- df[1:20,] df20\n## # A tibble: 20 x 2 ## journal n ## \u0026lt;chr\u0026gt; \u0026lt;int\u0026gt; ## 1 Nature 20 ## 2 Bioinformatics 16 ## 3 Nucleic Acids Research 13 ## 4 Nature Genetics 12 ## 5 Cancer Cell 10 ## 6 Science 9 ## 7 PLoS Computational Biology 8 ## 8 Cell 6 ## 9 Genome Research 6 ## 10 Nature Reviews Cancer 6 ## 11 PNAS 5 ## 12 Genome Biology 4 ## 13 Molecular Systems Biology 4 ## 14 AJHG 3 ## 15 Cancer Discovery 3 ## 16 Cancer Research 3 ## 17 Cell Reports 3 ## 18 Clinical Cancer Research 3 ## 19 Nature methods 3 ## 20 PLoS ONE 3 par(mar=c(4,12,2,2)) barplot(rev(df20$n), width=1, names.arg=rev(df20$journal), horiz=TRUE, col=\u0026#34;#fdbf6f\u0026#34;, las=1, main=\u0026#34;\u0026#34;, ylab=\u0026#34;\u0026#34;, xlab=\u0026#34;No. of Citations\u0026#34;, cex.axis=1, cex.names=1, cex.lab=1, tck=-0.03) I later post-processed the R-plots in Adobe Photoshop to get the figure below. ","date":1535760000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1535760000,"objectID":"4d8882916e7bb80aa2a211984391f816","permalink":"/post/bibliography_phdthesis/","publishdate":"2018-09-01T00:00:00Z","relpermalink":"/post/bibliography_phdthesis/","section":"post","summary":"Here, I attempted to visualize bibliography in my PhD thesis","tags":["data viz"],"title":"Visualization of Bibliography in my PhD Thesis","type":"post"},{"authors":["Raunak Shrestha"],"categories":null,"content":"","date":1533772800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1533772800,"objectID":"5a2b0991e8791da5bbde831c3f5c8c53","permalink":"/publication/2018_phdthesis/","publishdate":"2018-08-09T00:00:00Z","relpermalink":"/publication/2018_phdthesis/","section":"publication","summary":"","tags":null,"title":"Computational prioritization of cancer driver genes for precision oncology","type":"publication"},{"authors":null,"categories":null,"content":"Software HIT’nDRIVE - An algorithm for cancer driver genes prioritization\ncd-CAP - Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks\nData Analytics Group Segmentation and Diversity - Group segmentation and heterogeneity in the choice of cooking fuels Happiness in Post-Disaster Reconstruction - What Leads to Satisfaction in Post-Disaster Recovery? ","date":1530144000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1530144000,"objectID":"6fcae98d7df3b6c44952e7b5fed181e3","permalink":"/software/","publishdate":"2018-06-28T00:00:00Z","relpermalink":"/software/","section":"","summary":"Software HIT’nDRIVE - An algorithm for cancer driver genes prioritization\ncd-CAP - Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks\nData Analytics Group Segmentation and Diversity - Group segmentation and heterogeneity in the choice of cooking fuels Happiness in Post-Disaster Reconstruction - What Leads to Satisfaction in Post-Disaster Recovery?","tags":null,"title":"Software \u0026 Data Analytics","type":"page"},{"authors":null,"categories":null,"content":"I will be giving a talk at “MS09 - Peritoneal Mesothelioma” parallel mini-symposia at iMig2018 (May 4, 2018: Provinces II - Level 4, 11:00 - 12:30).\n","date":1525431600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1525431600,"objectID":"24bf0e04cf67ecc3467635d1de374451","permalink":"/talk/bap1-loss-predicts-therapeutic-vulnerability-in-malignant-peritoneal-mesothelioma/","publishdate":"2018-05-04T11:00:00Z","relpermalink":"/talk/bap1-loss-predicts-therapeutic-vulnerability-in-malignant-peritoneal-mesothelioma/","section":"event","summary":"I will be giving a talk at “MS09 - Peritoneal Mesothelioma” parallel mini-symposia at iMig2018 (May 4, 2018: Provinces II - Level 4, 11:00 - 12:30).","tags":[],"title":"BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal Mesothelioma","type":"event"},{"authors":["EE Gill","LS Chan","GL Winsor","N Dobson","R Lo","SJH Sui","BK Dhillon","PK Taylor","Raunak Shrestha","CoSpencer","REW Hancock","PJ Unrau","FSL Brinkman"],"categories":null,"content":"","date":1522108800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1522108800,"objectID":"476820afa15f49480effda15ed98f210","permalink":"/publication/2018_rnabacteria/","publishdate":"2018-03-27T00:00:00Z","relpermalink":"/publication/2018_rnabacteria/","section":"publication","summary":"","tags":null,"title":"High-throughput detection of RNA processing in bacteria","type":"publication"},{"authors":["H Sharifi-Noghabi","Y Liu","N Erho","Raunak Shrestha","M Alshalalfa","E Davicioni","CC Collins","M Ester"],"categories":null,"content":"","date":1519862400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1519862400,"objectID":"94e6484399256ff273f436e746db8626","permalink":"/publication/2018_dgs/","publishdate":"2018-03-01T00:00:00Z","relpermalink":"/publication/2018_dgs/","section":"publication","summary":"","tags":["Machine Learning","Prostate Cancer"],"title":"Deep Genomic Signature for early metastasis prediction in Prostate Cancer","type":"publication"},{"authors":["M Yamada","J Tang","J Lugo-Martinez","E Hodzic","Raunak Shrestha","A Saha","H Ouyang","D Yin","H Mamitsuka","SC Sahinalp","P Radivojac","F Menczer","Y Chang"],"categories":null,"content":"","date":1515369600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1515369600,"objectID":"e098ba55dfd99acd030be3ecb2272fb2","permalink":"/publication/2018_featureselection/","publishdate":"2018-01-08T00:00:00Z","relpermalink":"/publication/2018_featureselection/","section":"publication","summary":"","tags":["Machine Learning"],"title":"Ultra High-Dimensional Nonlinear Feature Selection for Big Biological Data","type":"publication"},{"authors":null,"categories":null,"content":"I will be giving a talk at the Terry Fox Research Institute 8th Annual Scientific Meeting (ASM). Also check for my poster during poster sessions.\n","date":1509879600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1509879600,"objectID":"e0793afa65130f0e754269b5597cec9b","permalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","publishdate":"2017-11-05T11:00:00Z","relpermalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","section":"event","summary":"I will be giving a talk at the Terry Fox Research Institute 8th Annual Scientific Meeting (ASM). Also check for my poster during poster sessions.","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"event"},{"authors":null,"categories":null,"content":"I will be giving a talk at the Terry Fox Research Institute [8th Annual Scientific Meeting (ASM)].\n","date":1509793200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1509793200,"objectID":"d5214097d1271bc436332f2b7f38698b","permalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","publishdate":"2017-11-04T11:00:00Z","relpermalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","section":"event","summary":"I will be giving a talk at the Terry Fox Research Institute [8th Annual Scientific Meeting (ASM)].","tags":[],"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"event"},{"authors":null,"categories":null,"content":"","date":1509534000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1509534000,"objectID":"8e10b7c945ef7d616453cdc3b4b40705","permalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","publishdate":"2017-11-01T11:00:00Z","relpermalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","section":"event","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"event"},{"authors":["Raunak Shrestha","E Hodzic","T Sauerwald","P Dao","K Wang","J Yeung","S Anderson","F Vandin","G Haffari","CC Collins","SC Sahinalp"],"categories":null,"content":" Here goes my paper that got published in @genomeresearch today :D https://t.co/yY8Ipch2Eg #Bioinformatics #Genomics #PrecisionOncology pic.twitter.com/ZxDCjzrQn6\n— Raunak Shrestha (@raunakms) July 18, 2017 Our paper highlighted in @CellSystemsCP \u0026#34;Identifying Rare Cancer Drivers\u0026#34; https://t.co/5ob895KjS4 #Bioinformatics #precisionmedicine pic.twitter.com/pW3rZuNneo\n— Raunak Shrestha (@raunakms) August 23, 2017 ","date":1500336000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1500336000,"objectID":"bb068087471aa1ea1144a30b6829638a","permalink":"/publication/2017_hitndrive/","publishdate":"2017-07-18T00:00:00Z","relpermalink":"/publication/2017_hitndrive/","section":"publication","summary":"Here goes my paper that got published in @genomeresearch today :D https://t.co/yY8Ipch2Eg #Bioinformatics #Genomics #PrecisionOncology pic.twitter.com/ZxDCjzrQn6\n— Raunak Shrestha (@raunakms) July 18, 2017 Our paper highlighted in @CellSystemsCP \"Identifying Rare Cancer Drivers\" https://t.","tags":["Algorithms","Cancer","Precision Oncology"],"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"publication"},{"authors":null,"categories":null,"content":"","date":1487323800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1487323800,"objectID":"f3f02c684dc23a6b628a8fbd3ad6a7a8","permalink":"/talk/translating-big-data-to-precision-oncology/","publishdate":"2017-02-17T09:30:00Z","relpermalink":"/talk/translating-big-data-to-precision-oncology/","section":"event","summary":"","tags":null,"title":"Translating Big-Data to Precision Oncology","type":"event"},{"authors":null,"categories":null,"content":"","date":1478196000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1478196000,"objectID":"334db1f59ab6a96835403b939b7ad809","permalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","publishdate":"2016-11-03T18:00:00Z","relpermalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","section":"event","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"event"},{"authors":null,"categories":null,"content":"","date":1476781200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1476781200,"objectID":"302d80209401ad1f747f59ad08d6eb76","permalink":"/talk/ashg-2016/","publishdate":"2016-10-18T09:00:00Z","relpermalink":"/talk/ashg-2016/","section":"event","summary":"","tags":null,"title":"ASHG-2016","type":"event"},{"authors":null,"categories":null,"content":"","date":1475485200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1475485200,"objectID":"4f81120144737efb54d8877f36e6b0cf","permalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","publishdate":"2016-10-03T09:00:00Z","relpermalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-for-precision-oncology/","section":"event","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology","type":"event"},{"authors":["ISU Luk","Raunak Shrestha","H Xue","Y Wang","F Zhang","D Lin","A Haegert","R Wu","X Dong","CC Collins","A Zoubeidi","ME Gleave","PW Gout","Y Wang"],"categories":null,"content":"","date":1474588800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1474588800,"objectID":"76d9847c9264e4c7e51195c46c2ac9ff","permalink":"/publication/2016_birc6/","publishdate":"2016-09-23T00:00:00Z","relpermalink":"/publication/2016_birc6/","section":"publication","summary":"","tags":["Cancer"],"title":"BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer","type":"publication"},{"authors":null,"categories":null,"content":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"e8f8d235e8e7f2efd912bfe865363fc3","permalink":"/project/example/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/example/","section":"project","summary":"An example of using the in-built project page.","tags":["Deep Learning"],"title":"Example Project","type":"project"},{"authors":null,"categories":null,"content":"","date":1461715200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461715200,"objectID":"d1311ddf745551c9e117aa4bb7e28516","permalink":"/project/external-project/","publishdate":"2016-04-27T00:00:00Z","relpermalink":"/project/external-project/","section":"project","summary":"An example of linking directly to an external project website using `external_link`.","tags":["Demo"],"title":"External Project","type":"project"},{"authors":["Raunak Shrestha"],"categories":["networks","data viz"],"content":"Genomic knowledge are often curated in the form of Genes. For example, a geneset of genes mapping to the chromosome locus chr8q24; a geneset of genes known to involve in DNA Repair Module, etc. Similarly, this data structure is also representative of patient-Genes data.\nThis can be thought of as a bipartite graph representing relation between individual Module to a gene. Often bioinformaticians are interested to visualize if there is any kind of relation between the Modules. This problem can be modeled as the conversion of two-mode network (bipartite graph) to one-mode network of Modules and visualize the resulting one-mode network. Here, I attempt to demonstrate how this can be achieved using R.\nDetails in github project\nLoad required libraries library(\u0026#34;stringr\u0026#34;) library(\u0026#34;igraph\u0026#34;) library(\u0026#34;RColorBrewer\u0026#34;) library(\u0026#34;gplots\u0026#34;) library(\u0026#34;cluster\u0026#34;) Load input data file #file.dat \u0026lt;- url(\u0026#34;https://dl.dropboxusercontent.com/u/30823824/dat_Genes.txt\u0026#34;) file.dat \u0026lt;- \u0026#34;data_table.tsv\u0026#34; dat \u0026lt;- read.delim(file.dat, header=TRUE, stringsAsFactors=FALSE) str(dat) ## \u0026#39;data.frame\u0026#39;: 37 obs. of 2 variables: ## $ SampleID: chr \u0026#34;T-01\u0026#34; \u0026#34;T-02\u0026#34; \u0026#34;T-03\u0026#34; \u0026#34;T-04\u0026#34; ... ## $ Genes : chr \u0026#34;FOXA1:GATA3:XBP1:COX17:KATNAL1:SCO2:STAT6:TFF3:THY1\u0026#34; \u0026#34;AR:NCOA3:SPDEF:TFF1:XBP1\u0026#34; \u0026#34;AR:FOXA1:MAP3K1:SP1:VAV3\u0026#34; \u0026#34;ESR1:LRBA:UBC:XBP1:ZFYVE16\u0026#34; ... Compute bipartite graph get.bip \u0026lt;- function(df){ ids \u0026lt;- df$SampleID genes \u0026lt;- sort(unique(unlist(str_split(df$Genes, \u0026#34;:\u0026#34;))),decreasing=F) bip \u0026lt;- matrix(0, nrow=length(ids), ncol=length(genes), dimnames=list(ids, genes))\nlist.genes \u0026lt;- str_split(df$Genes, \u0026#34;:\u0026#34;) list.gene.index \u0026lt;- lapply(list.genes, function(x) which(colnames(bip) %in% x))\nfor(i in 1:length(list.gene.index)){ bip[i,list.gene.index[[i]]] \u0026lt;- 1 } return(bip) }\nbip \u0026lt;- get.bip(dat)\nbip[1:5,1:5]\n## ABCC8 ADCY9 AKAP6 ALCAM APOB ## T-01 0 0 0 0 0 ## T-02 0 0 0 0 0 ## T-03 0 0 0 0 0 ## T-04 0 0 0 0 0 ## T-05 0 0 0 0 0 #dat$TotalGenes \u0026lt;- unlist(lapply(list.gene.index, length)) #dat$Color \u0026lt;- rev(jColFun(nrow(dat.sub))) jColFun \u0026lt;- colorRampPalette(brewer.pal(n = 9, \u0026#34;Purples\u0026#34;)) #Plot heatmap of the bi-partite graph heatmap.2(bip, col = jColFun(256), Colv=TRUE, Rowv = TRUE, dendrogram =\u0026#34;both\u0026#34;, trace=\u0026#34;none\u0026#34;, key=\u0026#34;FALSE\u0026#34;, hclustfun = function(x) hclust(x, method = \u0026#34;ward.D2\u0026#34;), distfun = function(x) dist(x, method = \u0026#34;binary\u0026#34;), colsep=c(1:500), rowsep=c(1:500), sepcolor=\u0026#34;grey90\u0026#34;, sepwidth=c(0.05,0.05), cexRow=0.7, cexCol=0.3) Compute CSI: Connection Specific Index # First compute pearson correlation dat.pcc \u0026lt;- cor(t(bip), method=\u0026#34;pearson\u0026#34;) dat.pcc[1:5,1:5] ## T-01 T-02 T-03 T-04 T-05 ## T-01 1.00000000 0.10974355 0.10974355 0.10974355 -0.02916748 ## T-02 0.10974355 1.00000000 0.17260274 0.17260274 -0.02144028 ## T-03 0.10974355 0.17260274 1.00000000 -0.03424658 -0.02144028 ## T-04 0.10974355 0.17260274 -0.03424658 1.00000000 -0.02144028 ## T-05 -0.02916748 -0.02144028 -0.02144028 -0.02144028 1.00000000 # Function to compute CSI: Connection Specific Index ### get.csi \u0026lt;- function(dat){ mat \u0026lt;- matrix(0, nrow=nrow(dat), ncol=ncol(dat), dimnames=list(rownames(dat),colnames(dat))) for(i in 1:nrow(dat)){ a \u0026amp;lt;- rownames(dat)[i] for(j in 1:ncol(dat)){ b \u0026amp;lt;- colnames(dat)[j] pcc.ab \u0026amp;lt;- dat[a,b] - 0.05 conn.pairs.a \u0026amp;lt;- colnames(dat)[which(dat[a,] \u0026amp;gt;= pcc.ab)] conn.pairs.b \u0026amp;lt;- rownames(dat)[which(dat[,b] \u0026amp;gt;= pcc.ab)] conn.pairs.ab \u0026amp;lt;- length(union(conn.pairs.a,conn.pairs.b)) n \u0026amp;lt;- nrow(dat) csi \u0026amp;lt;- 1 - (conn.pairs.ab/n) mat[i,j] \u0026amp;lt;- csi } } return(mat) }\ndat.csi \u0026lt;- get.csi(dat.pcc) dat.csi[1:5,1:5]\n## T-01 T-02 T-03 T-04 T-05 ## T-01 0.9729730 0.5405405 0.5675676 0.5945946 0.000000 ## T-02 0.5405405 0.9729730 0.5405405 0.5675676 0.000000 ## T-03 0.5675676 0.5405405 0.9729730 0.0000000 0.000000 ## T-04 0.5945946 0.5675676 0.0000000 0.9729730 0.000000 ## T-05 0.0000000 0.0000000 0.0000000 0.0000000 0.972973 heatmap.2(as.matrix(dat.pcc), col = jColFun(256), Colv=TRUE, Rowv = TRUE, dendrogram =\u0026#34;both\u0026#34;, trace=\u0026#34;none\u0026#34;, hclustfun = function(x) hclust(x, method = \u0026#34;ward.D2\u0026#34;), distfun = function(x) dist(x, method = \u0026#34;minkowski\u0026#34;, p=2), colsep=c(1:500), rowsep=c(1:500), sepcolor=\u0026#34;white\u0026#34;, sepwidth=c(0.05,0.05), key=\u0026#34;FALSE\u0026#34;,cexRow=0.8, cexCol=0.8, main=\u0026#34;PCC\u0026#34;) heatmap.2(as.matrix(dat.csi), col = jColFun(256), Colv=TRUE, Rowv = TRUE, dendrogram =\u0026#34;both\u0026#34;, trace=\u0026#34;none\u0026#34;, hclustfun = function(x) hclust(x, method = \u0026#34;ward.D2\u0026#34;), distfun = function(x) dist(x, method = \u0026#34;minkowski\u0026#34;, p=2), colsep=c(1:500), rowsep=c(1:500), sepcolor=\u0026#34;white\u0026#34;, sepwidth=c(0.05,0.05), key=\u0026#34;FALSE\u0026#34;,cexRow=0.8, cexCol=0.8, main=\u0026#34;CSI\u0026#34;) Visualizing the network #Convert the adjacency (corellation) matrix to an igraph object g \u0026lt;- graph.adjacency(dat.csi, mode = \u0026#34;undirected\u0026#34;, weighted=TRUE, diag=FALSE) g \u0026lt;- simplify(g, edge.attr.comb=list(weight=\u0026#34;sum\u0026#34;)) #get the node size ratio #for(ctr in 1:length(V(g)$name)){ # index \u0026lt;- which(dat$Module == V(g)$name[ctr]) # V(g)$size[ctr] \u0026lt;- dat$TotalGenes[index] # V(g)$color[ctr] \u0026lt;- dat$Color[index] #} V(g)$size \u0026lt;- 5 Set vertex attributes V(g)$label \u0026lt;- V(g)$name V(g)$label.color \u0026lt;- \u0026#34;black\u0026#34; …","date":1461110400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1461110400,"objectID":"7db7485fe761d33fa600884e274183b4","permalink":"/post/projections/","publishdate":"2016-04-20T00:00:00Z","relpermalink":"/post/projections/","section":"post","summary":"Often bioinformaticians are interested to visualize if there is any kind of relation between the Modules. This problem can be modeled as the conversion of two-mode network (bipartite graph) to one-mode network of Modules and visualize the resulting one-mode network. Here, I attempt to demonstrate how this can be achieved using R.","tags":["bioinformatics","data viz","networks"],"title":"Visualize and cluster one-mode projection of a bi-partite graph","type":"post"},{"authors":null,"categories":null,"content":"","date":1460451600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1460451600,"objectID":"6041d62d2d654cc856b2ac715191b187","permalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-to-guide-precision-cancer-medicine/","publishdate":"2016-04-12T09:00:00Z","relpermalink":"/talk/hitndrive-patient-specific-multi-driver-gene-prioritization-to-guide-precision-cancer-medicine/","section":"event","summary":"","tags":null,"title":"HIT'nDRIVE: Patient-Specific Multi-Driver Gene Prioritization to Guide Precision Cancer Medicine","type":"event"},{"authors":null,"categories":null,"content":"","date":1460019600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1460019600,"objectID":"1933b96dc6f12eb4f9872da220a0e960","permalink":"/talk/pcawg-2016/","publishdate":"2016-04-07T09:00:00Z","relpermalink":"/talk/pcawg-2016/","section":"event","summary":"","tags":null,"title":"PCAWG-2016","type":"event"},{"authors":["AW Wyatt","F Mo","K Wang","B McConeghy","S Brahmbhatt","L Jong","DM Mitchell","RL Johnston","A Haegert","E Li","J Liew","J Yeung","Raunak Shrestha","A Lapuk","A McPherson","R Shukin","RH Bell","S Anderson","J Bishop","A Hurtado-Coll","H Xiao","AM Chinnaiyan","R Mehra","D Lin","Y Wang","L Fazli","ME Gleave","S Volik","CC Collins"],"categories":null,"content":"","date":1409011200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1409011200,"objectID":"6b2d277c452c3166d1664f3c6869ba2c","permalink":"/publication/2014_highriskpca/","publishdate":"2014-08-26T00:00:00Z","relpermalink":"/publication/2014_highriskpca/","section":"publication","summary":"","tags":["Cancer","Prostate cancer"],"title":"Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer","type":"publication"},{"authors":["K Wang","Raunak Shrestha","AW Wyatt","A Reddy","J Lehar","Y Wang","A Lapuk","CC Collins"],"categories":null,"content":"","date":1405641600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1405641600,"objectID":"b6d8ab1da5a3e0ed4e4c4b8a51ebd4c5","permalink":"/publication/2014_drugresp/","publishdate":"2014-07-18T00:00:00Z","relpermalink":"/publication/2014_drugresp/","section":"publication","summary":"","tags":["Cancer"],"title":"A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines","type":"publication"},{"authors":["Raunak Shrestha","E Hodzic","J Yeung","K Wang","T Sauerwald","P Dao","S Anderson","H Beltran","MA Rubin","CC Collins","G Haffari","SC Sahinalp"],"categories":null,"content":"","date":1396310400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1396310400,"objectID":"4b3dfd6441f8860b07a24e56568ab042","permalink":"/publication/2014_hitndrive/","publishdate":"2014-04-01T00:00:00Z","relpermalink":"/publication/2014_hitndrive/","section":"publication","summary":"","tags":["Algorithms","Precision Oncology"],"title":"HIT'nDRIVE: Multi-driver gene prioritization based on hitting time","type":"publication"},{"authors":["Raunak Shrestha","RN Joshi","K Joshi","BH Poudel","BG Shrestha"],"categories":null,"content":"","date":1295308800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1295308800,"objectID":"05f33ea04fcb080831eb2d035ac84cfd","permalink":"/publication/2011_mtb/","publishdate":"2011-01-18T00:00:00Z","relpermalink":"/publication/2011_mtb/","section":"publication","summary":"","tags":null,"title":"Analysis of KatG Ser315Thr Mutation in Multidrug Resistant Mycobacterium tuberculosis and SLC11A1 Polymorphism in Multidrug Resistance Tuberculosis in Central Development Region of Nepal Using PCR-RFLP Technique: A Pilot Study","type":"publication"}]